46. 悪性関節リウマチ Malignant rheumatoid arthritis Clinical trials / Disease details

臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

4 trials found

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR1900024261	2019-07-15	2019-07-03	Efficacy and safety of sirolimusin new-onset rheumatoid arthritis: a prospective, double-blinded, ra ...	Efficacy and safety of sirolimusin new-onset rheumatoid arthritis: a prospective, double-blinded, ra ...	rheumatoid arthritis	A:methotrexate (7.5~15 mg/week)+ placbo (1 mg/d);B:sirolimus (1 mg/d) + methotrexate (7.5~15 mg/week);	The Second Hospital of Shanxi Medical University	NULL	Pending	18	65	Both	A:30;B:30;	Phase 4	China
2	ChiCTR-IPR-17011566	2017-07-01	2017-06-05	The efficacy and safety of sirolimusin refractory rheumatoid arthritis: A multi-center randomized co ...	The efficacy and safety of sirolimusin refractory rheumatoid arthritis: A multi-center randomized co ...	Rheumatoid Arthritis;M05.901	Sirolimus group: Sirolimus; Non-Sirolimus group:Glucocorticoids and Immunosuppressant;	the Second Hospital of Shanxi Medical University	NULL	Recruiting	18	65	Both	Sirolimus group:200; Non-Sirolimus group:100;		China
3	ChiCTR-IPR-17010307	2017-01-01	2017-01-01	The efficacy and safety of rapamycinin refractory rheumatoid arthritis: A multi-center randomized co ...	The efficacy and safety of rapamycinin refractory rheumatoid arthritis: A multi-center randomized co ...	Rheumatoid Arthritis;M05.901	Rapamycin group:Rapamycin;Non-rapamycin group :conventional glucocorticoids and DMARDs;	the Second Hospital of Shanxi Medical University	NULL	Recruiting	18	65	Both	Rapamycin group:200;Non-rapamycin group :100;		China
4	NCT00392951 (ClinicalTrials.gov)	December 2006	24/10/2006	Sirolimus for Autoimmune Disease of Blood Cells	Sirolimus for Patients With Chronic and/or Refractory Autoimmune Cytopenias: A Pilot Series	Autoimmune Pancytopenia;Autoimmune Lymphoproliferative Syndrome (ALPS);Evans Syndrome;Idiopathic Thr ...	Drug: sirolimus	Children's Hospital of Philadelphia	NULL	Completed	1 Year	30 Years	All	30	Phase 1/Phase 2	United States

First Previous1Next Last